Pharmacotherapy Approaches Toward Endocrine and Metabolic Diseases

Endocrine and metabolic diseases pose significant challenges to public health worldwide, affecting millions of individuals, impacting their quality of life. This new book offers an exploration of therapeutic strategies and advancements in the management of endocrine and metabolic disorders. Each chapter delves into specific disorders, discussing their pathophysiology, clinical manifestations, and cutting-edge therapeutic strategies.

Thakur Gurjeet Singh, PhD, MPharm, has 16 years of experience in industry, research, and teaching. He is working as Dean, Chitkara College of Pharmacy, Chitkara University, Punjab, India. He is engaged with projects on interception of nicotine, morphine, alcohol dependence, ischemia, diabetic neuropathy and nephropathy toxicology, epilepsy, Alzheimer disease, and stem cell research studies and handles affiliation formalities with the director office. He has also attended UGC networking courses and various preclinical and clinical research training programs. He has more than 182 research publications (international and national) and 25 book chapters, eight books and 58 patents filed under his name. To date, he has 170 Scopus-indexed publications in peer-reviewed journals (with 1778 citations, an h-index 22 and i10-index 58, impact factor: 482.5 and RG score: 37). He has attended more than 60 national and international conferences. He has guided theses for 65 MPharm students and is supervising 10 PhD candidates. He is a reviewer for various highly reputed international journals. He is a member secretary of the Committee for the Purpose of Control and Supervision of Experiments on Animals and is the In-Charge of the animal house facility at Chitkara College of Pharmacy. He is also a member secretary for institutional human ethical committee registered with the Department of Health Research and CDSCO New Delhi, India.

Sanjana Mehta, PhD, is working as an Assistant Professor and the Coordinator of the Institutional Innovation Cell (IIC) at Chitkara College of Pharmacy, Chitkara University, Punjab, India. With five years of academic experience, Dr. Mehta is proficient in clinical studies and medical statistics. Her research interest revolves around advanced pharmacotherapeutic approaches toward metabolic disorders. To date, she has mentored four PharmD students and is currently supervising four PharmD, two MPharm, and one PhD candidate. Dr. Mehta is actively involved in the CancerScreen project, a collaborative venture funded by DST, NewGen IEDC, and Chitkara University, Punjab. Her team has obtained one patent, and she also has a registered copyright to her credit. She has various published patents to her credit. She has also been honored with the Best PhD Award and Award of Honor at the National Pharma Tech & Youth Fest 2023 and 2024. Her academic background includes a PharmD and a PhD in Pharmaceutical Sciences.